• Home
  • News
  • Calendar
  • About DF/HCC
  • Membership
  • Visitor Center

Jeremy S. Abramson, M.D.

Instructor, Department of Medicine, Harvard Medical School

Clinical Director, Lymphoma Program, Cancer Center, Massachusetts General Hospital

Contact Info

Jeremy Abramson
Massachusetts General Hospital
Yawkey Center, Suite 7B

Boston, MA, 02114
Mailstop: Yawkey 7B
Phone: 617-726-8743
Fax: 617-643-1915
jabramson@partners.org

Assistant

Maureen Lucey
Cancer Center
Massachusetts General Hospital
55 Fruit Street
Boston, MA, 02114
Mailstop: Yawkey 7A
Phone: 617-726-8743
Fax: 617-643-1915
mlucey@partners.org

DF/HCC Program Affiliation

Lymphoma and Myeloma

Research Abstract

Dr. Abramson designs and conduct clinical research trials of novel therapies for the treatment of Hodgkin and non-Hodgkin lymphomas.

Publications

  • Abramson JS,Chatterji M,Rahemtullah A.Case records of the Massachusetts General Hospital. Case 39-2008. A 51-year-old woman with splenomegaly and anemia.N Engl J Med 2008 Dec 18;359(25):2707-18.
    19092156
  • Abramson JS,Chen W,Juszczynski P,Takahashi H,Neuberg D,Kutok JL,Takeyama K,Shipp MA.The heat shock protein 90 inhibitor IPI-504 induces apoptosis of AKT-dependent diffuse large B-cell lymphomas.British Journal of Haematology 2009 Feb;144(3):358-66.
    19036086
  • Abramson JS, Kotton CN, Elias N, Sahani DV, Hasserjian RP.Case records of the Massachusetts General Hospital. Case 8-2008. A 33-year-old man with fever, abdominal pain, and pancytopenia after renal transplantation.N Engl J Med 2008 Mar 13;358(11):1176-87.
    18337607
  • Abramson JS.T-cell/histiocyte-rich B-cell lymphoma and the paradox of the host immune response.Leuk Lymphoma 2007 Sep;48(9):1670-1.
    17786700
  • Juszczynski P, Ouyang J, Monti S, Rodig SJ, Takeyama K, Abramson J, Chen W, Kutok JL, Rabinovich GA, Shipp MA.The AP1-dependent secretion of galectin-1 by Reed Sternberg cells fosters immune privilege in classical Hodgkin lymphoma.Proc Natl Acad Sci U S A
    17670934
  • Rodig SJ, Abramson JS, Pinkus GS, Treon SP, Dorfman DM, Dong HY, Shipp MA, Kutok JL.Heterogeneous CD52 expression among hematologic neoplasms: implications for the use of alemtuzumab (CAMPATH-1H).Clin Cancer Res 2006 Dec 1;12(23):7174-9.
    17145843
  • Abramson JS.T-cell/histiocyte-rich B-cell lymphoma: biology, diagnosis, and management.Oncologist 2006 Apr;11(4):384-92.
    16614234
  • Abramson JS, Shipp MA.Advances in the biology and therapy of diffuse large B-cell lymphoma-moving towards a molecularly targeted approach.Blood 2005 Apr 26.
    15855278